Loading...
XHKG
0876
Market cap19mUSD
Oct 23, Last price  
1.46HKD
1D
-4.58%
1Q
-17.51%
Jan 2017
231.82%
Name

Kaisa Health Group Holdings Ltd

Chart & performance

D1W1MN
XHKG:0876 chart
P/E
—
P/S
1.09
EPS
—
Vol. 1Y
159.16%
Shs. 5Y
-54.27%
Rev. 5Y
-5.42%
Div Yld LY
—
Div Yld TTM
—
Revenues
139m
-24.95%
406,552,000394,334,000421,334,000331,563,000424,657,000379,886,000368,772,000315,985,000363,455,00099,873,000188,140,000226,703,000241,948,000251,618,000183,810,000209,626,000191,499,000185,882,000185,357,000139,112,000
Net income
-47m
L+0.70%
74,900,00085,254,000-70,824,00053,719,00079,502,000167,916,000312,808,000-43,672,000-90,005,000-10,009,000-1,645,0005,548,000-22,039,000-354,673,000-39,692,0002,359,000-123,318,0007,468,000-46,355,000-46,678,000
CFO
-47m
L+38.98%
85,102,0008,190,00046,287,00069,830,00075,878,00064,720,00074,999,00020,553,000-126,589,00056,616,00010,675,0005,959,000-7,083,0001,885,000-29,184,000-121,999,000-67,529,000-34,636,000-34,049,000-47,323,000
Dividend
May 22, 20140.3 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Qinghai Biotech Pharmaceutical Group Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Kaisa Health Group Holdings Limited and changed its name to Qinghai Biotech Pharmaceutical Group Limited in September 2026. Qinghai Biotech Pharmaceutical Group Limited was founded in 1971 and is headquartered in Central, Hong Kong.

Key people

Sisi Jiang
Chief Operating Officer · since 2015
Zhigang Xu
Vice President
Hoi Wun Hui
Financial Controller · since 2014
Ying Shing Kwok
Executive Director · since 2020
Kwok Leung Yu
Company Secretary · since 2018
Jun Luo
Chief Executive Officer, Co-Vice Chairman of the Board · since 2019
Tianyu Wu
Executive Co-Vice Chairman of the Board · since 2019
Hei Yu Fok
Non-Executive Independent Director · since 2018
Yanwen Liu
Independent Non-Executive Director · since 2017
Aiping Lyu
Non-Executive Independent Director · since 2018
URL
http://www.kaisahealth.com/
IPO date
Apr 10, 1997
Employees
860
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT